Coherus Biosciences CFO McDavid Stilwell resigns effective Dec 31, 2023

Coherus Oncology, Inc.

CFO McDavid Stilwell resigns to pursue other opportunities; effective Dec 31, 2023.
Resignation not related to any disagreement with company's operations, financials, or policies.
No successor named yet; Stilwell may provide transitional services by mutual agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

McDavid Stilwell

Chief Financial Officer

CHRS · Coherus Oncology, Inc.

Effective: 2023-12-31
Filed: December 7, 2023, 6:59 PM ET

McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

McDavid Stilwell resigned as Chief Financial Officer at Coherus Oncology, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.

View on SEC.gov

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-019636

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.